Concepedia

Keyi Zhu

KZ

Statistics

Publications

5

Citations

284

H-Index

5

Active since

2003

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Johns Hopkins University

Keyi Zhu is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, molecular oncology, and apoptosis.

Publications per year

2003–2018

5

Publications

5

Bortezomib Abolishes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via a p21-Dependent Mechanism in Human Bladder and Prostate Cancer Cells

Laura M. Lashinger, Keyi Zhu, Simon A. Williams et al. · Cancer Research · 2005 · 109 citations · Full text

, , +17

Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase.

Daoyan Wei, Erica L Richardson, Keyi Zhu et al. · PubMed · 2003 · 54 citations

, , +13

Control of HIF-1α Expression by eIF2α Phosphorylation–Mediated Translational Repression

Keyi Zhu, Wai-Kin Chan, John V. Heymach et al. · Cancer Research · 2009 · 53 citations · Full text

, , +15

Bortezomib inhibits docetaxel-induced apoptosis via a p21-dependent mechanism in human prostate cancer cells

Steven E. Canfield, Keyi Zhu, Simon A. Williams et al. · Molecular Cancer Therapeutics · 2006 · 44 citations · Full text

, , +17

HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells

Matthew White, Rebecca Schroeder, Keyi Zhu et al. · Oncogene · 2018 · 24 citations · Full text

, , +14

1–5 of 5